
IndraLab
Statements
Resveratrol inhibits NFKBIA. 8 / 8
1
|
4
3
reach
"Interestingly, Resveratrol, which blocks MyD88 independent, Toll and IL-1R domain containing adaptor inducing IFN-beta signaling in the TLR4 pathway [XREF_BIBR], inhibited I k Balpha degradation at the early time point, but not at a later time point (30 minutes) after LPS treatment."